Clover Biopharmaceuticals Ltd.'s total assets for Q2 2025 were ¥594.21M, a decrease of -26.89% from the previous quarter. HK:2197 total liabilities were ¥2.30B for the fiscal quarter, a -6.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.